Gentherm Inc

Gentherm Inc (THRM) Stock Analysis

$29.270

+0.676 (+2.31%)At close

Loading chart…
High
29.870
Open
28.580
VWAP
29.10
Volume
1.18M
Mkt Cap
1.55B
Low
28.170
Amount
34.39M
EV/EBITDA, TTM
9.65

Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets.

AI analysis of Gentherm Inc (THRM)

Hold

Gentherm Inc (THRM) is currently priced at $29.04, which is significantly below the analyst price target of $48 from JPMorgan, indicating a potential upside of approximately 65%. However, the stock has a low RSI of 24.39, suggesting it is oversold, but the recent trend shows a 20.11% decline over the last 20 days, indicating ongoing weakness. The significant increase in hedge fund selling by 8556.93% raises concerns about market sentiment. Therefore, while there is potential for recovery, the risks are substantial and a hold is recommended for now.

Analyst Ratings (9)

+48.04% upside
Buy
5 Buy
4 Hold
0 Sell
Current: 29.27
Low
42.00
Average
43.33
High
44.00

JPMorgan

2026-09-15

Price Target

$48

Overweight

CJS Securities

2026-09-14

Price Target

$50

Outperform

Roth Capital

2026-07-29

Price Target

$50

Buy

Freedom Broker

2026-07-24

Price Target

$40

Hold

JPMorgan

2026-07-24

Price Target

$48

Neutral

Valuation Metrics

The current forward P/E ratio for Gentherm Inc (THRM) is 11.09, compared to its 5-year average forward P/E of 20.02.

Forward P/E

Fair
5Y Average P/E
20.02
Current P/E
11.09
Overvalued
29.08
Undervalued
10.95

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.81
Current EV/EBITDA
9.65
Overvalued
13.95
Undervalued
5.68

Forward P/S

Fair
5Y Average P/S
1.16
Current P/S
0.94
Overvalued
1.69
Undervalued
0.62

Alphio AI Price Scenarios for THRM

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%THRM

$35.25

Scenario price

B

Base

Base · 50%THRM

$31.57

Scenario price

B

Bear

Bear · 25%THRM

$29.03

Scenario price

Whales holding THRM

S

Segall Bryant & Hamill, LLC

+ HoldingTHRM

-2.55%

3M Return

G

Global Alpha Capital Management Ltd.

+ HoldingTHRM

-5.67%

3M Return

Events Timeline

2026-09-17 (ET)

17:00:00

Gentherm and Modine Complete Merger Transaction, Distributing $58.35 Million Cash Dividend

2026-09-10 (ET)

13:30:00

Gentherm Shareholders Approve Merger with Modine

2026-07-23 (ET)

06:30:00

Gentherm Reports Q2 Revenue of $416.2M

06:30:00

FY26 Revenue Consensus at $1.56B, Adjusted EBITDA View Raised to $185M-$200M

06:30:00

Board Approves New $400M Stock Repurchase Program

News

THRM FAQ — answered by Alphio AI

Gentherm Incorporated is a provider of thermal and precision flow management technologies. The Automotive reporting segment comprises global automotive businesses, including the design, development, manufacturing and sales of its automotive climate and comfort solutions (including Climate Control Seats, Climate Control Interiors, and others), Valve Systems and other automotive products. The Medical reporting segment comprises the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. It also offers highly engineered, mission-critical thermal solutions serving commercial vehicles, off-highway equipment, light vehicle and power generation markets. It operates in the Consumer Cyclicals sector (MOTOR VEHICLE PARTS & ACCESSORIES industry).

Gentherm Inc (THRM) is currently priced at $29.04, which is significantly below the analyst price target of $48 from JPMorgan, indicating a potential upside of approximately 65%. However, the stock has a low RSI of 24.39, suggesting it is oversold, but the recent trend shows a 20.11% decline over the last 20 days, indicating ongoing weakness. The significant increase in hedge fund selling by 8556.93% raises concerns about market sentiment. Therefore, while there is potential for recovery, the risks are substantial and a hold is recommended for now.

9 analysts cover THRM: 5 rate it Buy, 4 Hold and 0 Sell. The average price target is 43.33.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading